Conservative therapy significantly reduces patients' chronic venous disease symptoms: A Caribbean insight into the VEIN Act Program. (October 2022)

• Record Type: Journal Article
• Authors: Dialsingh, Isaac; Mohammed, Saeed Rashaad; Medford, Rei Sebastian; Budhoo, Emerson; White-Gittens, Ian; Maharaj, Dale
• Is Part Of: Phlebology. Volume 37:Number 9(2022)
• Page Start: 651
• Page End: 661
• Publication Date: 2022-10
• Subjects: chronic venous disease -- compression -- micronized purified flavonoid fraction -- patient satisfaction -- lifestyle; Veins -- Diseases -- Periodicals; 616.14
• DOI: 10.1177/02683555221114542
• Languages: English
• ISSNs: 0268-3555

Abstract

Objectives: We sought to determine the baseline demographic and clinical characteristics of patients with Chronic Venous Disease (CVD) across the Caribbean, and to evaluate patients' compliance to conservative therapy and the effectiveness of such therapy in reducing patients' CVD symptoms. Method: Patients were enrolled into the VEIN Act Program, and their demographic data, CVD symptoms (and their intensity) and CEAP C-classification was recorded at the first visit. Patients were prescribed conservative therapy, and symptom intensity and patient compliance and satisfaction evaluated at a follow-up visit. Results: We enrolled 193 patients into the study, most of which (76%) were female, between 39–78 years (80%) and within the C2 -C4a classes (56.1%). Pain (61.1%) and heaviness (58.5%) were the most common symptoms. Patient compliance to the prescribed treatment was relatively high for all modalities (>75%) and most patients (92.1%) were at least somewhat satisfied with their treatment. Conclusions: Patient compliance to conservative therapy for management of CVD is high across the Caribbean, and such therapy is effective in reducing intensity of CVD symptoms.